Immunome, Inc. (IMNM)
21.60
+0.12
(+0.56%)
USD |
NASDAQ |
Apr 07, 16:00
21.60
0.00 (0.00%)
After-Hours: 20:00
Immunome Market Cap : 2.444B for April 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Krystal Biotech, Inc. | 7.707B |
| Scholar Rock Holding Corp. | 5.740B |
| Stoke Therapeutics, Inc. | 2.001B |
| Nurix Therapeutics, Inc. | 1.679B |
| CytomX Therapeutics, Inc. | 928.48M |
Market Cap Related Metrics
| PS Ratio | 265.80 |
| Price to Book Value | 3.789 |
| Price | 21.60 |
| Earnings Yield | -11.43% |